Evidence map›Paper›PMID 23201175›Full record

Trial reportDrug and alcohol dependence2013

"I just wanted to tell you that loperamide WILL WORK": a web-based study of extra-medical use of loperamide.

Raminta Daniulaityte, Robert Carlson, Russel Falck, Delroy Cameron, Sujan Perera, Lu Chen, Amit Sheth

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Evaluating Updated Fentanyl Immunoassays for Loperamide Interference.The journal of applied laboratory medicine · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Loperamide-Induced Ventricular Tachycardia Storm.Avicenna journal of medicine · 2022
    Article
  14. Article
  15. Article
  16. Loperamide-induced ventricular tachycardia storm.The British journal of cardiology · 2021
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Raminta DaniulaityteCenter for Interventions, Treatment, and Addictions Research, Department of Community Health, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, United States. raminta.daniulaityte@wright.edu
Robert Carlson
Russel Falck
Delroy Cameron
Sujan Perera
Lu Chen
Amit Sheth
Wright State University · US

Funding

A Study of Social Web Data on Buprenorphine Abuse Using Semantic Web TechnologyR21DA030571 · NIDA · WRIGHT STATE UNIVERSITY · PI DANIULAITYTE, RAMINTA, SHETH, AMIT P · 2011 to 2012
$402k
NIDA NIH HHS R21 DA030571
6 · The paper itself

Abstract

aimsMany websites provide a means for individuals to share their experiences and knowledge about different drugs. Such User-Generated Content (UGC) can be a rich data source to study emerging drug use practices and trends. This study examined UGC on extra-medical use of loperamide among illicit opioid users.

methodsA website that allows for the free discussion of illicit drugs and is accessible for public viewing was selected for analysis. Web-forum posts were retrieved using web crawlers and retained in a local text database. The database was queried to extract posts with a mention of loperamide and relevant brand/slang terms. Over 1290 posts were identified. A random sample of 258 posts was coded using NVivo to identify intent, dosage, and side-effects of loperamide use.

resultsThere has been an increase in discussions related to loperamide's use by non-medical opioid users, especially in 2010-2011 Loperamide was primarily discussed as a remedy to alleviate a broad range of opioid withdrawal symptoms, and was sometimes referred to as "poor man's" methadone. Typical doses ranged 70-100mg per day, much higher than an indicated daily dose of 16mg.

conclusionsThis study suggests that loperamide is being used extra-medically to self-treat opioid withdrawal symptoms. There is a growing demand among people who are opioid dependent for drugs to control withdrawal symptoms, and loperamide appears to fit that role. The study also highlights the potential of the Web as a "leading edge" data source in identifying emerging drug use practices.

Indexed as

AdvertisingAnalgesics, OpioidHumansInternetLoperamideOpioid-Related DisordersSelf CareSubstance-Related DisordersSubstance Withdrawal SyndromeAnalgesics, OpioidLoperamide

Identifiers

PMID23201175
PMCPMC3633632
OpenAlexW2026850615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.